Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics

VBLT POWR Grades

• Sentiment is the dimension where VBLT ranks best; there it ranks ahead of 93.72% of US stocks.
• VBLT's strongest trending metric is Growth; it's been moving down over the last 161 days.
• VBLT's current lowest rank is in the Momentum metric (where it is better than 4.06% of US stocks).

VBLT Stock Summary

• Vascular Biogenics Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.43% of US listed stocks.
• With a price/sales ratio of 124.9, Vascular Biogenics Ltd has a higher such ratio than 97.65% of stocks in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for VBLT comes in at -36.23% -- higher than that of only 10.81% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Vascular Biogenics Ltd are SYBX, AYLA, ALT, GNCA, and ARDS.
• VBLT's SEC filings can be seen here. And to visit Vascular Biogenics Ltd's official web site, go to www.vblrx.com.

VBLT Valuation Summary

• VBLT's price/sales ratio is 186.4; this is 1542.29% higher than that of the median Healthcare stock.
• VBLT's price/sales ratio has moved NA NA over the prior 84 months.
• VBLT's EV/EBIT ratio has moved up 3.9 over the prior 84 months.

Below are key valuation metrics over time for VBLT.

VBLT Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -23.97%.
• Its 4 year net cashflow from operations growth rate is now at -3.84%.
• The 5 year net cashflow from operations growth rate now stands at -3.84%.

VBLT's revenue has moved up $136,000 over the prior 30 months.

The table below shows VBLT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	0.777	-25.545	-28.07
2021-06-30	0.771	-22.289	-27.345
2021-03-31	0.741	-23.552	-25.155
2020-12-31	0.922	-23.378	-24.225
2020-09-30	0.843	-19.831	-22.697
2020-06-30	0.729	-19.999	-21.776

VBLT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VBLT has a Quality Grade of C, ranking ahead of 42.6% of graded US stocks.
• VBLT's asset turnover comes in at 0.015 -- ranking 380th of 682 Pharmaceutical Products stocks.
• ISEE, SRNE, and CNCE are the stocks whose asset turnover ratios are most correlated with VBLT.

The table below shows VBLT's key quality metrics over time.